223 related articles for article (PubMed ID: 33238582)
1. Phase I/II Clinical Trial of the Anti-Podoplanin Monoclonal Antibody Therapy in Dogs with Malignant Melanoma.
Kamoto S; Shinada M; Kato D; Yoshimoto S; Ikeda N; Tsuboi M; Yoshitake R; Eto S; Hashimoto Y; Takahashi Y; Chambers J; Uchida K; Kaneko MK; Fujita N; Nishimura R; Kato Y; Nakagawa T
Cells; 2020 Nov; 9(11):. PubMed ID: 33238582
[TBL] [Abstract][Full Text] [Related]
2. Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin.
Kato Y; Mizuno T; Yamada S; Nakamura T; Itai S; Yanaka M; Sano M; Kaneko MK
Monoclon Antib Immunodiagn Immunother; 2018 Nov; 37(5):218-223. PubMed ID: 30362926
[TBL] [Abstract][Full Text] [Related]
3. PDPN Is Expressed in Various Types of Canine Tumors and Its Silencing Induces Apoptosis and Cell Cycle Arrest in Canine Malignant Melanoma.
Shinada M; Kato D; Kamoto S; Yoshimoto S; Tsuboi M; Yoshitake R; Eto S; Ikeda N; Saeki K; Hashimoto Y; Takahashi Y; Chambers J; Uchida K; Kaneko MK; Fujita N; Nishimura R; Kato Y; Nakagawa T
Cells; 2020 May; 9(5):. PubMed ID: 32380790
[TBL] [Abstract][Full Text] [Related]
4. Epitope Mapping of Monoclonal Antibody PMab-38 Against Dog Podoplanin.
Chang YW; Yamada S; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Dec; 36(6):291-295. PubMed ID: 29161183
[TBL] [Abstract][Full Text] [Related]
5. Podoplanin Expression in Canine Melanoma.
Ogasawara S; Honma R; Kaneko MK; Fujii Y; Kagawa Y; Konnai S; Kato Y
Monoclon Antib Immunodiagn Immunother; 2016 Dec; 35(6):304-306. PubMed ID: 27918691
[TBL] [Abstract][Full Text] [Related]
6. Antibody-Drug Conjugates Using Mouse-Canine Chimeric Anti-Dog Podoplanin Antibody Exerts Antitumor Activity in a Mouse Xenograft Model.
Kato Y; Ito Y; Ohishi T; Kawada M; Nakamura T; Sayama Y; Sano M; Asano T; Yanaka M; Okamoto S; Handa S; Komatsu Y; Takei J; Kaneko MK
Monoclon Antib Immunodiagn Immunother; 2020 Apr; 39(2):37-44. PubMed ID: 32182186
[TBL] [Abstract][Full Text] [Related]
7. The mouse-canine chimeric anti-dog podoplanin antibody P38B exerts antitumor activity in mouse xenograft models.
Kato Y; Ohishi T; Kawada M; Maekawa N; Konnai S; Itai S; Yamada S; Kaneko MK
Biochem Biophys Rep; 2019 Mar; 17():23-26. PubMed ID: 30519645
[TBL] [Abstract][Full Text] [Related]
8. Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma.
Shinada M; Kato D; Motegi T; Tsuboi M; Ikeda N; Aoki S; Iguchi T; Li T; Kodera Y; Ota R; Hashimoto Y; Takahashi Y; Chambers J; Uchida K; Kato Y; Nishimura R; Nakagawa T
Mol Cancer Res; 2023 Nov; 21(11):1205-1219. PubMed ID: 37493578
[TBL] [Abstract][Full Text] [Related]
9. Novel knock-in mouse model for the evaluation of the therapeutic efficacy and toxicity of human podoplanin-targeting agents.
Ukaji T; Takemoto A; Shibata H; Kakino M; Takagi S; Katayama R; Fujita N
Cancer Sci; 2021 Jun; 112(6):2299-2313. PubMed ID: 33735501
[TBL] [Abstract][Full Text] [Related]
10. Development of Core-Fucose-Deficient Humanized and Chimeric Anti-Human Podoplanin Antibodies.
Kaneko MK; Ohishi T; Nakamura T; Inoue H; Takei J; Sano M; Asano T; Sayama Y; Hosono H; Suzuki H; Kawada M; Kato Y
Monoclon Antib Immunodiagn Immunother; 2020 Oct; 39(5):167-174. PubMed ID: 33085938
[TBL] [Abstract][Full Text] [Related]
11. Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma.
Xu M; Wang X; Pan Y; Zhao X; Yan B; Ruan C; Xia L; Zhao Y
BMC Cancer; 2019 Jun; 19(1):599. PubMed ID: 31208371
[TBL] [Abstract][Full Text] [Related]
12. Antipodoplanin antibody enhances the antitumor effects of CTLA-4 blockade against malignant mesothelioma by natural killer cells.
Yoneda H; Mitsuhashi A; Yoshida A; Ogino H; Itakura S; Nguyen NT; Nokihara H; Sato S; Shinohara T; Hanibuchi M; Abe S; Kaneko MK; Kato Y; Nishioka Y
Cancer Sci; 2024 Feb; 115(2):357-368. PubMed ID: 38148492
[TBL] [Abstract][Full Text] [Related]
13. Potential to involve multiple effector cells with human recombinant interleukin-2 and antiganglioside monoclonal antibodies in a canine malignant melanoma immunotherapy model.
Helfand SC; Soergel SA; Donner RL; Gan J; Hank JA; Lindstrom MJ; Sondel PM
J Immunother Emphasis Tumor Immunol; 1994 Oct; 16(3):188-97. PubMed ID: 7834118
[TBL] [Abstract][Full Text] [Related]
14. A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma.
Maekawa N; Konnai S; Takagi S; Kagawa Y; Okagawa T; Nishimori A; Ikebuchi R; Izumi Y; Deguchi T; Nakajima C; Kato Y; Yamamoto K; Uemura H; Suzuki Y; Murata S; Ohashi K
Sci Rep; 2017 Aug; 7(1):8951. PubMed ID: 28827658
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of novel anti-podoplanin antibody NZ-12 against malignant pleural mesothelioma in an orthotopic xenograft model.
Abe S; Kaneko MK; Tsuchihashi Y; Izumi T; Ogasawara S; Okada N; Sato C; Tobiume M; Otsuka K; Miyamoto L; Tsuchiya K; Kawazoe K; Kato Y; Nishioka Y
Cancer Sci; 2016 Sep; 107(9):1198-205. PubMed ID: 27294401
[TBL] [Abstract][Full Text] [Related]
16. The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity.
Kato Y; Kunita A; Abe S; Ogasawara S; Fujii Y; Oki H; Fukayama M; Nishioka Y; Kaneko MK
Oncotarget; 2015 Nov; 6(34):36003-18. PubMed ID: 26416352
[TBL] [Abstract][Full Text] [Related]
17. Podoplanin promotes cell proliferation, survival, and migration of canine non-tonsillar squamous cell carcinoma.
Shinada M; Kato D; Tsuboi M; Ikeda N; Aoki S; Iguchi T; Li T; Kodera Y; Ota R; Koseki S; Shibahara H; Takahashi Y; Hashimoto Y; Chambers JK; Uchida K; Noguchi S; Kato Y; Nishimura R; Nakagawa T
J Vet Med Sci; 2023 Oct; 85(10):1068-1073. PubMed ID: 37544715
[TBL] [Abstract][Full Text] [Related]
18. PMab-52: Specific and Sensitive Monoclonal Antibody Against Cat Podoplanin for Immunohistochemistry.
Yamada S; Itai S; Nakamura T; Yanaka M; Saidoh N; Chang YW; Handa S; Harada H; Kagawa Y; Ichii O; Konnai S; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Oct; 36(5):224-230. PubMed ID: 28737447
[TBL] [Abstract][Full Text] [Related]
19. Specific Detection of Dog Podoplanin Expressed in Renal Glomerulus by a Novel Monoclonal Antibody PMab-38 in Immunohistochemistry.
Honma R; Kaneko MK; Ogasawara S; Fujii Y; Konnai S; Takagi M; Kato Y
Monoclon Antib Immunodiagn Immunother; 2016 Aug; 35(4):212-6. PubMed ID: 27380308
[TBL] [Abstract][Full Text] [Related]
20. Chimeric Anti-Human Podoplanin Antibody NZ-12 of Lambda Light Chain Exerts Higher Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity Compared with NZ-8 of Kappa Light Chain.
Kaneko MK; Abe S; Ogasawara S; Fujii Y; Yamada S; Murata T; Uchida H; Tahara H; Nishioka Y; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):25-29. PubMed ID: 28157429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
